Browsing by Yonsei Author : Cho, Jae Yong

Name:
Cho, Jae Yong [조재용] http://orcid.org/0000-0002-0926-1819
Department :
College of Medicine (의과대학) - Dept. of Internal Medicine (내과학교실)
Y-HRN :
(Yonsei Health Research Network)
Scopus ID :
(36805119200)

Keyword Cloud

Researcher Network

This table browses all dspace content
Issue DateTitleJournal Title
2020A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data GASTRIC CANCER
2020Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer GASTRIC CANCER
2019A phase I/II study of poziotinib combined with paclitaxel and trastuzumab in patients with HER2-positive advanced gastric cancerGASTRIC CANCER
2018Clinical and genomic landscape of gastric cancer with a mesenchymal phenotype Nature Communications
2018Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG)GASTRIC CANCER
2018Efficacy of adjuvant chemotherapy for completely resected stage IB non-small cell lung cancer: a retrospective study JOURNAL OF THORACIC DISEASE
2018Subgroup analysis of East Asian patients in REGARD: A phase III trial of ramucirumab and best supportive care for advanced gastric cancerASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
2017Ramucirumab as Second-Line Treatment in Patients With Advanced Hepatocellular Carcinoma: Analysis of REACH Trial Results by Child-Pugh ScoreJAMA ONCOLOGY
2017Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01)CANCER
2017Survival analysis based on human epidermal growth factor 2 status in stage II-III gastric cancer. WORLD JOURNAL OF GASTROENTEROLOGY
2017Prognostic Factor Analysis of Overall Survival in Gastric Cancer from Two Phase III Studies of Second-line Ramucirumab (REGARD and RAINBOW) Using Pooled Patient Data JOURNAL OF GASTRIC CANCER
2017Efficacy of Sequential Ipilimumab Monotherapy versus Best Supportive Care for Unresectable Locally Advanced/Metastatic Gastric or Gastroesophageal Junction CancerCLINICAL CANCER RESEARCH
2017Clinical Significance of Four Molecular Subtypes of Gastric Cancer Identified by The Cancer Genome Atlas ProjectCLINICAL CANCER RESEARCH
2017Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trialLANCET
2017Comparison of capecitabine and oxaliplatin with S-1 as adjuvant chemotherapy in stage III gastric cancer after D2 gastrectomyPLOS ONE
2016Overexpression of Endoplasmic Reticulum Oxidoreductin 1-α (ERO1L) Is Associated with Poor Prognosis of Gastric Cancer CANCER RESEARCH AND TREATMENT
2016Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II TrialJOURNAL OF CLINICAL ONCOLOGY
2016Development and Validation of a Six-Gene Recurrence Risk Score Assay for Gastric Cancer CLINICAL CANCER RESEARCH
2016Subgroup analysis of East Asians in RAINBOW: A phase 3 trial of ramucirumab plus paclitaxel for advanced gastric cancerJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2016A Randomized Phase II Study of FOLFOX With or Without the MET Inhibitor Onartuzumab in Advanced Adenocarcinoma of the Stomach and Gastroesophageal Junction ONCOLOGIST
2016Phase II trial of dacomitinib in patients with HER2-positive gastric cancerGASTRIC CANCER
2015혈액투석 환자에서 발생한 카포시육종의 Pazopanib 치료 증례 Korean Journal of Medicine
2015Gemcitabine Combined with Capecitabine Compared to Gemcitabine with or without Erlotinib as First-Line Chemotherapy in Patients with Advanced Pancreatic Cancer CANCER RESEARCH AND TREATMENT
2015Randomized, Double-Blind Phase II Trial With Prospective Classification by ATM Protein Level to Evaluate the Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients With Recurrent or Metastatic Gastric CancerJOURNAL OF CLINICAL ONCOLOGY
2015Comparison of surgery plus chemotherapy and palliative chemotherapy alone for advanced gastric cancer with krukenberg tumor CANCER RESEARCH AND TREATMENT
2014Clinical practice guidelines for gastric cancer in Korea: An evidence-based approach JOURNAL OF GASTRIC CANCER
2014Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trialLANCET
2014Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study (START) JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
2014Targeted therapy in gastric cancer: Personalizing cancer treatment based on patient genome WORLD JOURNAL OF GASTROENTEROLOGY
2013Molecular diagnosis for personalized target therapy in gastric cancer JOURNAL OF GASTRIC CANCER
2013Clinicopathologic implications of the BRAF(V600E) mutation in papillary thyroid cancer: a subgroup analysis of 3130 cases in a single centerTHYROID
2013Overexpression of miR-196b and HOXA10 characterize a poor-prognosis gastric cancer subtype WORLD JOURNAL OF GASTROENTEROLOGY
2013Design of precise third-line therapy for gastric cancer: target or chemotherpy? KOREAN JOURNAL OF INTERNAL MEDICINE
2013성인에서 천미부 기형종의 선암으로 전환 1예 Korean Journal of Medicine
2012복강 내에서 발견된 기관지원성낭종 내의 선암 1예 Korean Journal of Medicine
2012AMPKα modulation in cancer progression: multilayer integrative analysis of the whole transcriptome in Asian gastric cancer. CANCER RESEARCH
2012Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.LANCET
2012Comparison of two inflammation-based prognostic scores in patients with unresectable advanced gastric cancerONCOLOGY
2012Treatment outcome of patients with anaplastic thyroid cancer: a single center experience YONSEI MEDICAL JOURNAL
2012Overexpression of the M2 isoform of pyruvate kinase is an adverse prognostic factor for signet ring cell gastric cancer WORLD JOURNAL OF GASTROENTEROLOGY
2012Thioredoxin and thioredoxin-interacting protein as prognostic markers for gastric cancer recurrence WORLD JOURNAL OF GASTROENTEROLOGY
2011Gene expression signature-based prognostic risk score in gastric cancer CLINICAL CANCER RESEARCH
2011Gene expression signature analysis identifies vorinostat as a candidate therapy for gastric cancer. PLOS ONE
2011Antifibrotic effects of magnesium lithospermate B on hepatic stellate cells and thioacetamide-induced cirrhotic rats. EXPERIMENTAL AND MOLECULAR MEDICINE
2011Prognostic factors of second and third line chemotherapy using 5-fu with platinum, irinotecan, and taxane for advanced gastric cancer. CANCER RESEARCH AND TREATMENT
2010Prognostic biomarkers for esophageal adenocarcinoma identified by analysis of tumor transcriptome PLOS ONE
2010Outcome of adjuvant therapy for gallbladder cancerONCOLOGY
2009Gemcitabine and oxaliplatin combination as first-line treatment for advanced pancreatic cancer: a multicenter phase II studyCANCER CHEMOTHERAPY AND PHARMACOLOGY
2009Erlotinib monotherapy for stage IIIB/IV non-small cell lung cancer: a multicenter trial by the Korean Cancer Study Group JOURNAL OF THORACIC ONCOLOGY
2009Oxaliplatin combined with continuous infusion of 5-fluorouracil as first-line chemotherapy in patients with metastatic or recurrent gastric adenocarcinoma.CHEMOTHERAPY
12

Browse

Links